Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Amylin/Calcitonin Receptor–Mediated Signaling in POMC Neurons Influences Energy Balance and Locomotor Activity in Chow-Fed Male Mice
Bernd Coester, Christina Koester-Hegmann, Thomas A. Lutz, et al.
Diabetes (2020) Vol. 69, Iss. 6, pp. 1110-1125
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease
Laurie L. Baggio, Daniel J. Drucker
Molecular Metabolism (2020) Vol. 46, pp. 101090-101090
Open Access | Times Cited: 219
CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond
Andrew F. Russo, Debbie L. Hay
Physiological Reviews (2022) Vol. 103, Iss. 2, pp. 1565-1644
Open Access | Times Cited: 157
Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat
David S. Mathiesen, Asger Lund, Tina Vilsbøll, et al.
Frontiers in Endocrinology (2021) Vol. 11
Open Access | Times Cited: 56
Creating the amylin story
Thomas A. Lutz
Appetite (2022) Vol. 172, pp. 105965-105965
Open Access | Times Cited: 33
Mediators of Amylin Action in Metabolic Control
Christina N. Boyle, Yi Zheng, Thomas A. Lutz
Journal of Clinical Medicine (2022) Vol. 11, Iss. 8, pp. 2207-2207
Open Access | Times Cited: 33
Amylin brain circuitry
Lavinia Boccia, Salome Gamakharia, Bernd Coester, et al.
Peptides (2020) Vol. 132, pp. 170366-170366
Open Access | Times Cited: 48
Long-acting amylin analogues for the management of obesity
David S. Mathiesen, Jonatan I. Bagger, Filip K. Knop
Current Opinion in Endocrinology Diabetes and Obesity (2022) Vol. 29, Iss. 2, pp. 183-190
Closed Access | Times Cited: 27
Central control of energy balance by amylin and calcitonin receptor agonists and their potential for treatment of metabolic diseases
Hannah Louise Zakariassen, Linu M. John, Thomas A. Lutz
Basic & Clinical Pharmacology & Toxicology (2020) Vol. 127, Iss. 3, pp. 163-177
Open Access | Times Cited: 21
Neurochemical Basis of Inter-Organ Crosstalk in Health and Obesity: Focus on the Hypothalamus and the Brainstem
Dhanush Haspula, Zhenzhong Cui
Cells (2023) Vol. 12, Iss. 13, pp. 1801-1801
Open Access | Times Cited: 7
DACRA induces profound weight loss, satiety control, and increased mitochondrial respiratory capacity in adipose tissue
E. A. Petersen, Ida Blom, Simone Anna Melander, et al.
International Journal of Obesity (2024)
Closed Access | Times Cited: 2
NN1213 – A Potent, Long-Acting, and Selective Analog of Human Amylin
Kirsten Dahl, Kirsten Raun, Jakob Lerche Hansen, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 14, pp. 11688-11700
Open Access | Times Cited: 2
A selective role for receptor activity‐modifying proteins in subchronic action of the amylin selective receptor agonist NN1213 compared with salmon calcitonin on body weight and food intake in male mice
Soraya Arrigoni, Christelle Le Foll, Andrea Cabak, et al.
European Journal of Neuroscience (2021) Vol. 54, Iss. 3, pp. 4863-4876
Open Access | Times Cited: 16
ASB4 modulates central melanocortinergic neurons and calcitonin signaling to control satiety and glucose homeostasis
Eirini Vagena, Jasmina Crneta, Pauline Engström, et al.
Science Signaling (2022) Vol. 15, Iss. 733
Closed Access | Times Cited: 12
Hypothalamic anorexigenic signaling pathways (leptin, amylin, and proopiomelanocortin) are semaglutide (GLP-1 analog) targets in obesity control in mice
Fabiane Ferreira Martins, Thiago Santos-Reis, Thatiany de Souza Marinho, et al.
Life Sciences (2022) Vol. 313, pp. 121268-121268
Open Access | Times Cited: 12
Viral depletion of calcitonin receptors in the area postrema: A proof-of-concept study
Bernd Coester, Christelle Le Foll, Thomas A. Lutz
Physiology & Behavior (2020) Vol. 223, pp. 112992-112992
Open Access | Times Cited: 16
Calcitonin receptor antibody validation and expression in the rodent brain
Erica R. Hendrikse, Tayla A. Rees, Zoe Tasma, et al.
Cephalalgia (2022) Vol. 42, Iss. 9, pp. 815-826
Open Access | Times Cited: 10
Whole‐brain mapping of amylin‐induced neuronal activity in receptor activity–modifying protein 1/3 knockout mice
Grethe Skovbjerg, Urmas Roostalu, Henrik H. Hansen, et al.
European Journal of Neuroscience (2021) Vol. 54, Iss. 1, pp. 4154-4166
Open Access | Times Cited: 14
Distributed amylin receptor signaling and its influence on motivated behavior
Katherine A. Kern, Elizabeth G. Mietlicki‐Baase
Physiology & Behavior (2020) Vol. 222, pp. 112958-112958
Closed Access | Times Cited: 14
Noradrenaline signaling in the LPBN mediates amylin's and salmon calcitonin's hypophagic effect in male rats
Lavinia Boccia, Christelle Le Foll, Thomas A. Lutz
The FASEB Journal (2020) Vol. 34, Iss. 11, pp. 15448-15461
Open Access | Times Cited: 13
Targeting appetite and satiety in diabetes and obesity, via G protein-coupled receptors
Noah B.C. Piper, Emily A. Whitfield, Gregory D. Stewart, et al.
Biochemical Pharmacology (2022) Vol. 202, pp. 115115-115115
Closed Access | Times Cited: 7
Characterization of Antibodies against Receptor Activity-Modifying Protein 1 (RAMP1): A Cautionary Tale
Erica R. Hendrikse, Tayla A. Rees, Zoe Tasma, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 16035-16035
Open Access | Times Cited: 5
The long-acting amylin/calcitonin receptor agonist ZP5461 suppresses food intake and body weight in male rats
Lauren M. Stein, Lauren E. McGrath, Rinzin Lhamo, et al.
AJP Regulatory Integrative and Comparative Physiology (2021) Vol. 321, Iss. 2, pp. R250-R259
Open Access | Times Cited: 6
The calcitonin receptor is the main mediator of LAAMA's body weight lowering effects in male mice
Salome Gamakharia, Christelle Le Foll, Wolfgang Rist, et al.
European Journal of Pharmacology (2021) Vol. 908, pp. 174352-174352
Open Access | Times Cited: 6
Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic
Francesca Logiacco, Laura Cathleen Grzegorzek, Elizabeth Cordell, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 2
Amylin Pharmacology in Alzheimer’s Disease Pathogenesis and Treatment
Gemma Casadesús, Rachel R. Corrigan, Helen Piontkivska
Current Neuropharmacology (2021) Vol. 20, Iss. 10, pp. 1894-1907
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top